The Centers for Disease Control and Prevention (CDC) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in China and which has now been detected in almost 70 locations internationally, including in the United States. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19"). IEHP will continually update you on the latest recommendations, news, and resources on COVID-19 as it becomes available.
Coronavirus (COVID-19) Advisory
COVID-19 Symptoms and Members Care
For a complete list of COVID-19 symptoms and step-by-step member direction, visit our COVID-19 member page.
COVID-19 Therapeutics Available for Members
In an effort to provide the most up-to-date treatments against COVID-19, IEHP continues to maintain a list of providers, including but not limited to infusion clinics, ancillary, hospital and non-hospital based infusion centers offering COVID-19 infusion therapy treatment. Under all Member coverage, outpatient COVID therapeutics will be offered immediately after a Member is determined to be clinically eligible under and Emergency Use Authorization (EUA).
For more information, Providers can utilize the COVID-19 Therapeutics Clinical Consult Line to connect with other clinicians for a free and confidential consultation on COVID-19 testing and treatment: 1-866-268-4322 (1-866-COVID-CA).
Related Resources
- Community Resource Centers Community Resource Centers Community Resource Centers
- Diabetes Prevention Program - Skinny Gene Project Diabetes Prevention Program - Skinny Gene Project Diabetes Prevention Program - Skinny Gene Project
- Illness Management Resources for Members Illness Management Resources for Members Illness Management Resources for Members